Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
56.64
-1.41 (-2.44%)
Aug 14, 2025, 2:02 PM - Market open

Hinge Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023
Period Ending
Jun '25 Dec '24 Dec '23
Net Income
-426.88-11.93-108.14
Depreciation & Amortization
1.832.352.13
Other Amortization
39.9733.5123.84
Loss (Gain) From Sale of Investments
0.650.54-10.76
Stock-Based Compensation
591.120.741.65
Provision & Write-off of Bad Debts
5.75.414.86
Other Operating Activities
-101.154.8813.11
Change in Accounts Receivable
-37.64-1.34-23.13
Change in Inventory
-3.640.6110.57
Change in Accounts Payable
3.68-10.9811.56
Change in Unearned Revenue
87.7377.1635.97
Change in Other Net Operating Assets
-69.48-51.95-25.56
Operating Cash Flow
91.8949-63.91
Capital Expenditures
-0.72-1.04-1.98
Sale (Purchase) of Intangibles
-3.75-2.73-2.64
Investment in Securities
-9.4222.096.12
Investing Cash Flow
-17.918.311.5
Issuance of Common Stock
256.260.610.49
Other Financing Activities
-57.81-2.81-3.49
Financing Cash Flow
-73.81-2.2-3
Net Cash Flow
0.1865.11-65.41
Free Cash Flow
91.1747.96-65.89
Free Cash Flow Margin
18.96%12.29%-22.51%
Free Cash Flow Per Share
4.163.54-5.06
Levered Free Cash Flow
-73.18-
Unlevered Free Cash Flow
-73.18-
Change in Working Capital
-19.3513.59.41
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q